If you've cycled through medications and therapy and still feel the weight, you're not out of options. For treatment-resistant depression, psychedelic-assisted therapy has helped many people feel like themselves again — sometimes within days.
Yes, with growing evidence. Psilocybin matched escitalopram in a randomised trial and ibogaine produced an 87% average fall in depression scores in a small Stanford study. These are supervised, prepared sessions with integration afterwards — not a pill — and only about a third of people reach remission on a first antidepressant.
Depression is one of the most widespread conditions in the world — and the standard first answer, an SSRI, works for fewer people than most assume.
STAR*D was long cited as proof antidepressants work. A reanalysis of its own data tells a more sobering story.
The famous "67% get better" figure was overstated. A protocol-faithful reanalysis found the true cumulative remission was about 35%.
Only about a third reach remission on their first antidepressant — most keep trying, and many never fully respond.
STAR*D had no placebo or waitlist arm — so it's impossible to separate the drug's effect from the placebo response and the passage of time.
Especially for treatment-resistant depression — and the anxiety that so often rides alongside it — the results have caught the field's attention.
In a head-to-head trial, 57% of the psilocybin group were in remission at 6 weeks — versus 28% on escitalopram.
The FDA approved esketamine (a ketamine nasal spray) for treatment-resistant depression — with improvement often within 24 hours.
Unlike SSRIs, ketamine can lift severe depression in hours or days — a lifeline when the need is urgent.
Conventional antidepressants can take weeks and don't work for everyone. These treatments appear to work differently — helping the brain form new connections and, for many, lifting the weight far more quickly. See it explained by the people leading the research.
There's no single locked path. Most psychedelic-assisted therapies can benefit depression in some way — these are the ones that most often fit, and an advisor tailors the choice to you.
A deep reset that some describe as reconnecting them to meaning and to themselves.
Explore 5-MeO-DMT → When depression & dependence overlapWhere depression sits alongside substance use, ibogaine can interrupt the cycle in a supervised setting.
Explore ibogaine → Not sure?Depression often overlaps with anxiety or trauma. An advisor helps find what genuinely fits.
Speak with an advisor →Small things start to matter again — a song, a meal, a morning.
The exhaustion lifts enough to actually do the things you'd given up on.
Not forced positivity — a quiet, genuine sense that the future is open again.
Talk with an advisor who understands treatment-resistant depression and has been through these treatments personally. Only verified providers, honest guidance, your pace.
Speak With An Advisor →Psilocybin has the most controlled evidence; ketamine and esketamine are the only legal US options today; ibogaine shows strong early signals in veterans. The right one depends on your history, medications and what has already failed.
Most clinical programs prioritise people who have not responded to standard care, because that is where the evidence and the need are strongest.
SSRIs and other medications can blunt or interact with psychedelics. Any change is planned with a physician before treatment, never on your own.
Call or text (866) 435-7057 or request a consultation. We review your history and explain where each treatment tends to fit.
